Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Senior VP & CIO | August 12, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date August 12, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,636.0547 |
Reported balance
After 2026-08-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-12 · Sale · Disposed 1,000 · Balance 21,636.0547 |
| Common StockSEC Table I · non-derivative | Direct | 20,636.0547 |
Reported balance
After 2026-08-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-08-14 · Sale · Disposed 1,000 · Balance 20,636.0547 |
| Common StockSEC Table I · non-derivative | Direct | 19,636.0547 |
Reported balance
After 2026-08-17 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-08-17 · Sale · Disposed 1,000 · Balance 19,636.0547 |
| Common StockSEC Table I · non-derivative | Direct | 18,636.0547 |
Reported balance
After 2026-08-19 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-08-19 · Sale · Disposed 1,000 · Balance 18,636.0547 |
| Common StockSEC Table I · non-derivative | Direct | 17,636.0547 |
Reported balance
After 2026-08-20 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-08-20 · Sale · Disposed 1,000 · Balance 17,636.0547 |
| Common StockSEC Table I · non-derivative | Direct | 16,636.0547 |
Reported balance
After 2026-08-25 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2026-08-25 · Sale · Disposed 1,000 · Balance 16,636.0547 |
| Common StockSEC Table I · non-derivative | Direct | 15,636.0547 |
Reported balance
After 2026-08-28 transaction · row 7
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 7 · 2026-08-28 · Sale · Disposed 1,000 · Balance 15,636.0547 F1: Total amount of shares beneficially owned following transactions reported on this form. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $94.10 · Expires 2029-03-05 | Direct | 4,000 |
Reported balance
Holding disclosure · report date 2026-08-12 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 4,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $90.62 · Expires 2030-02-24 | Direct | 9,000 |
Reported balance
Holding disclosure · report date 2026-08-12 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 9,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $157.13 · Expires 2031-02-23 | Direct | 14,000 |
Reported balance
Holding disclosure · report date 2026-08-12 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 14,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Total amount of shares beneficially owned following transactions reported on this form.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 04, 2021 Filed Nov 9, 2021 23:11 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 24,000 | $72.94 | $1,750,560.00 |
DisclosureSEC source: 0001437749-21-025977 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,648.2702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 19:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 742 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004224 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,648.2702 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2022, the next 33 1/3% vesting on 1/1/2023, and the final 33 1/3% vesting on 1/1/2024. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 798 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003503 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,516 F1 · shares: Restricted shares subject to a three-year vesting schedule. The shares will vest 33 1/3% on 1/1/2021, 66 2/3% on 1/1/2022, and 100% on 1/1/2023. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 22:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 962 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-003293 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,448 F1 · shares: Restricted shares subject to a three-year vesting schedule. The shares will vest 33 1/3% on 1/1/2020, 66 2/3% on 1/1/2021, and 100% on 1/1/2022. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:54 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 16,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-19-003086 · rdgdoc.xml · derivative · entry 3 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 40,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 14, 2019, the Compensation Committee amended the option to grant a 30 day window to exercise up to 40% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 14, 2019, the Compensation Committee amended the option to grant a 30 day window to exercise up to 40% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:54 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 14,514 | $84.03 | $1,219,611.42 |
DisclosureSEC source: 0001437749-19-003086 · rdgdoc.xml · nonDerivative · entry 2 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,486 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of common shares owned following transactions reported on this form. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:54 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 16,000 | $72.94 | $1,167,040.00 |
DisclosureSEC source: 0001437749-19-003086 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 14, 2019, the Compensation Committee amended the option to grant a 30 day window to exercise up to 40% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 19:46 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 40,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001047335-17-000071 · edgar.xml · derivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2022-03-11 F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.